Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 30:12:2379-2390.
doi: 10.2147/JPR.S206519. eCollection 2019.

Factors associated with waiting times for persons with rheumatic conditions in multidisciplinary pain treatment facilities

Affiliations

Factors associated with waiting times for persons with rheumatic conditions in multidisciplinary pain treatment facilities

Simon Deslauriers et al. J Pain Res. .

Abstract

Objectives: Access to multidisciplinary pain treatment facilities (MPTF) in Canada is limited by long waiting lists. However, little is known about the factors associated with access to MPTF specifically for persons with rheumatic conditions. This study aimed to 1) determine the waiting time for services in publicly funded MPTF for persons with rheumatic conditions in the province of Quebec, Canada, as well as 2) identify the factors associated with waiting time.

Methods: This study was conducted using the Quebec Pain Registry, a large database of patients who received pain management services in MPTF. Sociodemographic and clinical variables were assessed for potential associations with waiting time. Descriptive, bivariate analyses and multiple linear regression analyses were conducted.

Results: A total of 3,665 patients with rheumatic conditions were identified within the registry. Patients had a mean age of 55±14 years and the majority were women (65.7%). The average waiting time was 241.2±308.9 days (median=126), with 34.2% of the patients waiting longer than 6 months before having a first appointment. Results indicate that longer pain duration, lower household income, pain onset following a motor vehicle accident, having fibromyalgia, being on permanent disability or unemployed and being referred by a family physician (versus specialist) were significantly associated with longer waiting times.

Conclusions: Many patients with rheumatic conditions (especially fibromyalgia) face long delays before receiving services in Quebec's MPTF. This study identified several factors associated with waiting time and emphasizes the need to improve access to pain management services.

Keywords: access; chronic pain; multidisciplinary pain treatment facilities; rheumatic conditions; waiting time.

PubMed Disclaimer

Conflict of interest statement

Dr Anne Marie Pinard reports grants from Medisca, personal fees from Allergan and Paladin Labs, speaker fees from Purdue Pharma, Allergan and Paladins Labs outside the submitted work and has served as a member of the external advisory board to Purdue Pharma and Paladin Labs. The authors report no other conflicts of interest in this work.

References

    1. 'Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ, Coggeshall M. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015. a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–1602. - PMC - PubMed
    1. Barbour KE, Helmick CG, Boring M, Brady TJ. Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation - United States, 2013–2015. MMWR Morb Mortal Wkly Rep. 2017;66(9):246–253. doi:10.15585/mmwr.mm6609e1 - DOI - PMC - PubMed
    1. Reis C, Viana Queiroz M. Prevalence of self-reported rheumatic diseases in a Portuguese population. Acta Reumatol Port. 2014;39(1):54–59. - PubMed
    1. van der Heijde D, Daikh DI, Betteridge N, et al. Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). Ann Rheum Dis. 2018;77(6):829–832. doi:10.1136/annrheumdis-2017-212565 - DOI - PubMed
    1. Sarzi-Puttini P, Atzeni F, Clauw DJ, Perrot S. The impact of pain on systemic rheumatic diseases. Best Pract Res Clin Rheumatol. 2015;29(1):1–5. doi:10.1016/j.berh.2015.05.004 - DOI - PubMed